Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients Peng Su Cong-xian Yang Xing-guang Wang BMC Infectious Diseases(2024) A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology ...
In physics terms, the world economy is a dissipative structure, just as all plants, animals and ecosystems are. All dissipative structures have finite lifespans, including the world economy. This finding is not well known because academic researchers seem to operate in ivory towers...
Paxlovid has just been approved by the U.S. Food and Drug Administration issued with an emergency use authorization (EUA) and by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK (https://www.fda.gov/news-events/press-announcements/coronavirus-COVID-19-update-fda-...
FDA granted EUA (November 2021) for pills of molnupiravir by Merck and Paxlovid (a protease inhibitor) by Pfizer to be taken orally at the first signs of COVID-19 to stave off its severe clinical consequences based on unpublished data of clinical trials by the respective drug companies. ...
Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients. Clin. Infect. Dis. 2022, 76, e342–e349. [Google Scholar] [CrossRef] Mahase, E. Covid-19: Molnupiravir Reduces Risk of Hospital Admission or Death by 50% in Patients at Risk, MSD Reports. ...